These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 29893593)

  • 1. Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study.
    Berg AK; Nørgaard K; Thyssen JP; Zachariae C; Hommel E; Rytter K; Svensson J
    Diabetes Technol Ther; 2018 Jul; 20(7):475-482. PubMed ID: 29893593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequencies of dermatological complications in children using insulin pumps or sensors.
    Berg AK; Olsen BS; Thyssen JP; Zachariae C; Simonsen AB; Pilgaard K; Svensson J
    Pediatr Diabetes; 2018 Jun; 19(4):733-740. PubMed ID: 29484783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes.
    Christensen MO; Berg AK; Rytter K; Hommel E; Thyssen JP; Svensson J; Nørgaard K
    Diabetes Technol Ther; 2019 Apr; 21(4):215-221. PubMed ID: 30943072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
    Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
    Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes.
    Binder E; Lange O; Edlinger M; Meraner D; Abt D; Moser C; Steichen E; Hofer SE
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):260-4. PubMed ID: 25607337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.
    Rigo RS; Levin LE; Belsito DV; Garzon MC; Gandica R; Williams KM
    J Diabetes Sci Technol; 2021 Jul; 15(4):786-791. PubMed ID: 32389062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.
    ; Weinzimer S; Xing D; Tansey M; Fiallo-Scharer R; Mauras N; Wysocki T; Beck R; Tamborlane W; Ruedy K
    Pediatr Diabetes; 2009 Apr; 10(2):91-6. PubMed ID: 19175899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Description of the Skin Reactions Associated with Adhesives in Diabetes Technology Devices in an Adult Population: Results of the CUTADIAB Study.
    Diedisheim M; Pecquet C; Julla JB; Carlier A; Potier L; Hartemann A; Jacqueminet S; Vidal-Trecan T; Gautier JF; Dubois Laforgue D; Fagherazzi G; Roussel R; Larger E; Sola-Gazagnes A; Riveline JP
    Diabetes Technol Ther; 2023 Apr; 25(4):279-286. PubMed ID: 36763338
    [No Abstract]   [Full Text] [Related]  

  • 14. An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life.
    Jenkins AJ; Krishnamurthy B; Best JD; Cameron FJ; Colman PG; Hamblin PS; O'Connell MA; Rodda C; Teede H; O'Neal DN
    Diabetes Technol Ther; 2011 Feb; 13(2):105-9. PubMed ID: 21284476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sectional survey and retrospective analysis of a large cohort of adults with type 1 diabetes with long-term continuous subcutaneous insulin infusion treatment.
    Joubert M; Morera J; Vicente A; Rod A; Parienti JJ; Reznik Y
    J Diabetes Sci Technol; 2014 Sep; 8(5):1005-10. PubMed ID: 24876454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salient characteristics of youth with type 1 diabetes initiating continuous glucose monitoring.
    Telo GH; Volkening LK; Butler DA; Laffel LM
    Diabetes Technol Ther; 2015 Jun; 17(6):373-8. PubMed ID: 25749206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections.
    Rodbard D; Jovanovic L; Garg SK
    Diabetes Technol Ther; 2009 Dec; 11(12):757-65. PubMed ID: 20001676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of Insulin Regimen and Glucose Outcomes with Short-Term Real-Time Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Control on Multiple Daily Injections: The Adult DIACCOR Study.
    Picard S; Hanaire H; Reznik Y; Benhamou PY; Fendri S; Dufaitre L; Leutenegger E; Guerci B
    Diabetes Technol Ther; 2018 Jun; 20(6):403-412. PubMed ID: 29847735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study.
    Moreno-Fernandez J; Gomez FJ; Gazquez M; Pedroche M; García-Manzanares A; Tenias JM; Benito P; Gomez IR
    Diabetes Technol Ther; 2013 Jul; 15(7):596-600. PubMed ID: 23631604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.